Literature DB >> 12670336

Anaplastic large cell lymphoma in Japanese children: retrospective analysis of 34 patients diagnosed at the National Research Institute for Child Health and Development.

Tetsuya Mori1, Nobutaka Kiyokawa, Hiroyuki Shimada, Jun Miyauchi, Junichiro Fujimoto.   

Abstract

This report presents a retrospective study of 34 Japanese children diagnosed at a single laboratory as having anaplastic large cell lymphoma (ALCL). Most of the pathological features of the Japanese ALCL children observed, such as anaplastic lymphoma kinase protein expression, in addition to most of the clinical characteristics and the outcomes of the patients, are very similar to those reported by European groups. To our knowledge, this is the first report describing the details of the clinicopathological features of Japanese ALCL patients. A further International study, including Japanese patients, might contribute to the establishment of an optimal treatment for paediatric ALCL.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12670336     DOI: 10.1046/j.1365-2141.2003.04249.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  7 in total

1.  Hematopoietic stem cell transplantation in relapsed ALK+ anaplastic large cell lymphoma in children and adolescents: a study on behalf of the SFCE and SFGM-TC.

Authors:  M Strullu; C Thomas; M-C Le Deley; A Chevance; J Kanold; Y Bertrand; C Jubert; J-H Dalle; C Paillard; A Baruchel; L Lamant; G Michel; L Brugières
Journal:  Bone Marrow Transplant       Date:  2015-03-30       Impact factor: 5.483

2.  Prognostic impact of minimal disseminated disease and immune response to NPM-ALK in Japanese children with ALK-positive anaplastic large cell lymphoma.

Authors:  Yuka Iijima-Yamashita; Tetsuya Mori; Atsuko Nakazawa; Reiji Fukano; Tetsuya Takimoto; Masahito Tsurusawa; Ryoji Kobayashi; Keizo Horibe
Journal:  Int J Hematol       Date:  2017-10-13       Impact factor: 2.490

Review 3.  Advances in hematopoietic stem cell transplantation in childhood and adolescent lymphomas.

Authors:  Mitchell S Cairo; Willi Woessmann; John Pagel
Journal:  Biol Blood Marrow Transplant       Date:  2012-10-13       Impact factor: 5.742

4.  CD30-Positive Anaplastic Lymphoma Kinase-Negative Systemic Anaplastic Large-Cell Lymphoma in a 9-Year-Old Boy.

Authors:  Jeong Eun Kim; Eui Hyun Oh; Young Suck Ro; Joo Yeon Ko
Journal:  Ann Dermatol       Date:  2016-05-25       Impact factor: 1.444

5.  Gene Expression Signature Associated with Clinical Outcome in ALK-Positive Anaplastic Large Cell Lymphoma.

Authors:  Camille Daugrois; Chloé Bessiere; Sébastien Dejean; Véronique Anton-Leberre; Thérèse Commes; Stephane Pyronnet; Pierre Brousset; Estelle Espinos; Laurence Brugiere; Fabienne Meggetto; Laurence Lamant
Journal:  Cancers (Basel)       Date:  2021-11-03       Impact factor: 6.639

6.  Characteristics and Outcomes of Chinese Children With Advanced Stage Anaplastic Large Cell Lymphoma: A Single-Center Experience.

Authors:  Yu-Tong Zhang; Li-Zhe Wang; Jian Chang
Journal:  Front Oncol       Date:  2022-02-15       Impact factor: 6.244

Review 7.  Immune Response against ALK in Children with ALK-Positive Anaplastic Large Cell Lymphoma.

Authors:  Serena Stadler; Vijay Kumar Singh; Fabian Knörr; Christine Damm-Welk; Wilhelm Woessmann
Journal:  Cancers (Basel)       Date:  2018-04-10       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.